Canary Capital’s Newest ETF: Staked Injective Investment Opportunities?

Jakarta, Pintu News – Canary Capital recently announced a major step in the cryptocurrency investment world by registering a statutory trust in Delaware for their proposed Injective Staked ETF (INJ).

The move is part of their efforts to launch a US-based investment product that tracks Injective (INJ) prices and incorporates staking rewards.

Registration and Approval Process

As a first step, Canary Capital will have to file a Form S-1 with the US Securities and Exchange Commission (SEC) to get approval to launch the ETF. This process is important as the SEC oversees securities offerings in the US.

Once the form is filed, the SEC will review the application before granting approval. In addition, Canary Capital will also need to file Form 19b-4 through the exchange where the ETF will be listed. These steps are crucial to bringing the ETF to market.

Read also: Investors Move Away from Bitcoin and US Dollar, What Are Their Options?

Staked Injective ETF Advantages

The Injective Staked ETF proposed by Canary Capital aims to track the spot price of Injective (INJ) while also earning additional INJ tokens through staking. Staking is a process where cryptocurrency holders lock in their tokens to support network operations, such as transaction validation, in exchange for rewards. =

As such, investors in this ETF will gain exposure to the market price of INJ as well as the staking rewards generated through the Injective blockchain. This provides convenience for investors as it allows them to gain exposure to INJ without having to stake directly.

Read also: US SEC Delays Decision on Polka Dot and Hedera ETFs, What’s the Impact?

Competition in the Crypto Products Market

Canary Capital’s announcement comes amid a slew of financial companies that have begun offering crypto-backed investment products. One example is a product from 21Shares, an Injective Staking Exchange Traded Product (ETP) called AINJ, which is already available on Euronext Amsterdam and Paris.

The product is 100% physically backed and reinvests the staking rewards into the ETP, tracking the performance of INJ. Several leading financial institutions including Interactive Brokers, Saxo Bank, Swissquote, and eToro have backed this ETP.

Conclusion

With Canary Capital’s move to launch an Injective Staked ETF, the opportunities for investors to get involved in the cryptocurrency market are expanding. The product not only offers direct exposure to the price of Injective (INJ) but also ease of participation in the staking rewards program, which could be of particular interest to investors looking for diversification in their crypto investments.

That’s the latest information about crypto. Follow us on Google News to stay up-to-date on the world of crypto and blockchain technology.

Enjoy an easy and secure crypto trading experience by downloading Pintu crypto app via Google Play Store or App Store now. Get a web trading experience with advanced trading tools such as pro charting, various types of order types, and portfolio tracker only at Pintu Pro. Pintu Pro Futures is also available, where you can buy bitcoin leverage, trade btc futures, eth futures and sol futures easily from your desktop!

*Disclaimer

This content aims to enrich readers’ information. Pintu collects this information from various relevant sources and is not influenced by outside parties. Note that an asset’s past performance does not determine its projected future performance. Crypto trading activities have high risk and volatility, always do your own research and use cold cash before investing. All activities of buying and selling bitcoin and other crypto asset investments are the responsibility of the reader.

Reference

• Coingape. Canary Capital Registers Staked Injective ETF in Delaware. Accessed on June 11, 2025
• Featured Image: AMB Crypto